Synapse - Deena Mary Atieh Graham

Deena Mary Atieh Graham

Research Focus

Former Employee. Basking Ridge; Assistant Attending

Recent additions – View all

Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
Journal Article

Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
Clinical Breast Cancer (2010)

Fulltext@MSK | Save
Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
Meeting Abstract

Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
Cancer Research (2009)

Fulltext@MSK | Save
Targeted therapy for breast cancer
Book Section

Atieh, D. M.; Vahdat, L. T.
In Kaufman, H. L.; Wadler, S.; Antman, K. (Eds.) Molecular Targeting in Oncology (2008)

Fulltext@MSK | Save

Co-authors at MSK

2

D'Andre...
2

Drullinsky
2

Fornier
2

Gilewski
2

Hudis
2

Lake
2

Norton
2

Seidman
2

Sugarman
2

Traina
2

Troso-S...
1

Brennan
1

Bromberg
1

Chen
1

Coit
1

Currie
1

Dang
1

Dickler
1

Gorsky
1

Mills
1

Modi
1

Patel
1

Patil
1

Robson
1

Sklarin
1

Theodou...
1

Wasserh...
1

Yuan
1

Zucker

Types of Work

Publications